Veklury® (remdesivir) – New drug approval
October 22, 2020 - The FDA announced the approval of Gilead’s Veklury (remdesivir), for adults and pediatric patients (12 years of age and older and weighing at least 40 kg) for the treatment of coronavirus disease 2019 (COVID-19) requiring hospitalization.
Download PDF
